Literature DB >> 6693419

Binding of fibronectin by the acute phase reactant C-reactive protein.

E M Salonen, T Vartio, K Hedman, A Vaheri.   

Abstract

Following tissue injury, the concentration of C-reactive protein (CRP) is known to increase in plasma rapidly, while that of fibronectin often decreases. We now report that CRP immobilized onto polystyrene surfaces binds soluble plasma fibronectin (Kd = 1.5 X 10(-8) M). The binding of fibronectin by CRP was relatively sensitive to ionic conditions, being maximal at physiological NaCl concentrations. A decrease of pH from neutral to 5-6 greatly enhanced the binding of fibronectin by CRP. Ca2+ ions at greater than 1 mM inhibited binding. No binding was observed between fibronectin and CRP in soluble phase. CRP was found also to bind fibrinogen, which competed with fibronectin for CRP-binding sites. This was shown to explain why fibronectin was effectively bound from serum but not from plasma by immobilized CRP. The amount of CRP immobilized was critical in binding fibronectin; a too dense molecular layer of CRP inhibited the binding, as did the postsaturation of free surfaces with albumin, which itself was not bound by CRP. Soluble fibronectin agglutinated CRP-coated latex particles. Most or all of the CRP-binding activity in the fibronectin molecule was localized to the 120-140-kilodalton fragment, which also contains cell-binding and heparin-binding domains of fibronectin. The results provide a link between acute phase response and tissue repair.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693419

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Molecular genetics, structure, and function of C-reactive protein.

Authors:  J M Kilpatrick; J E Volanakis
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Functional Transformation of C-reactive Protein by Hydrogen Peroxide.

Authors:  Sanjay K Singh; Avinash Thirumalai; Asmita Pathak; Donald N Ngwa; Alok Agrawal
Journal:  J Biol Chem       Date:  2017-01-17       Impact factor: 5.157

3.  The role of phosphate groups in the interaction of human C-reactive protein with galactan polysaccharides.

Authors:  J Soelter; G Uhlenbruck
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

4.  Changes in plasma fibronectin during allogeneic bone marrow transplantation.

Authors:  D R Norfolk; M Bowen
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

5.  Affinity of fibronectin for polyclonal IgG.

Authors:  M Salvarrey; A Rostagno
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

6.  C-reactive protein-mediated complement activation in polymyalgia rheumatica and other systemic inflammatory diseases.

Authors:  P Vaith; G M Hänsch; H H Peter
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

7.  Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein.

Authors:  Sanna Taskinen; Petri T Kovanen; Hanna Jarva; Seppo Meri; Markku O Pentikäinen
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

8.  Uptake of toxic silica particles by isolated rat liver macrophages (Kupffer cells) is receptor mediated and can be blocked by competition.

Authors:  V Kolb-Bachofen
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

9.  Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications.

Authors:  Madathilparambil V Suresh; Sanjay K Singh; Alok Agrawal
Journal:  J Biol Chem       Date:  2004-09-28       Impact factor: 5.157

10.  Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.

Authors:  Kim M Lonergan; Raj Chari; Bradley P Coe; Ian M Wilson; Ming-Sound Tsao; Raymond T Ng; Calum Macaulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.